Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
![](https://aquariusph.com/app/uploads/2021/07/france_770.jpg)
Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways
![](https://aquariusph.com/app/uploads/2021/11/ecp-pub-770.jpg)
Mapping and comparing COPD Care Pathways across 10 countries to understand barriers to optimal care: clinicians’ perspectives
![](https://aquariusph.com/app/uploads/2022/05/copd_poster_770x225-1.png)
Further evidence that rapid near-patient testing for chlamydia and gonorrhoea in sexual health clinics benefits patient care
![](https://aquariusph.com/app/uploads/2021/12/binx-news770x225.jpg)
Care Pathway Mapping for Dravet Syndrome (DS) Patients in England
![](https://aquariusph.com/app/uploads/2021/11/ispor-fin-pub-770-1.png)
User experience and workflow performance: a pilot evaluation of the Genius Digital Diagnostics System for screening cervical cytology samples
![](https://aquariusph.com/app/uploads/2022/11/ECC-2021-770x225-1.png)
Analysing the COPD care pathway in Japan, Canada, England, and Germany: a global view
![](https://aquariusph.com/app/uploads/2021/09/ERS-poster-web-pic_3.jpg)
A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada
![](https://aquariusph.com/app/uploads/2021/07/toronto-770.jpg)
A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting
![](https://aquariusph.com/app/uploads/2021/07/ispor-fince-pub-770.jpg)
Determining the Relationship of Seizures, Seizure Free Days and Other Predictors of Health Related Quality of Life in Patients with Dravet Syndrome (DS) and Their Carers
![](https://aquariusph.com/app/uploads/2021/07/ispor-fin-pub-770.png)